Font size
WorksheetsPharm Week 8/9 Test 3
Total questions: 59
Worksheet time: 44mins
Glycogenolysis
Glucose to Glucagon
Amino Acid to Glycogen
Glycogen to Glucose
Amino Acid to Glucose
Gluconeogenesis
Amino Acid to Glucose
Glucose to Glycogen
Glycogen to Glucose
Amino Acid to Glycogen
Glucagon is produced where
Alpha cells of pancreas
Beta cells of pancreas
Delta cells of pancreas
Gamma Cells of pancreas
Insulin is released in response to decreased blood glucose
True
False
Select all that are secreted from Beta cells of pancreas
Insulin
Glucagon
Amylin
Pepsin
Select the incretins that enhance glucose stimulated insulin secretion in B cells following food ingestion
GLP-1
DPP-4
GIP
Glucagon
Which incretin slows gastric emptying, decreases glucagon secretion, and stimulates satiety
GLP-1
GIP
Which adipose tissue hormone stimulates the hypothalamus to decrease appetite
Adiponectin
Leptin
GIP
DPP-4
Which of the following is described best by a resistance to insulin leading to a relative deficiency of insulin secretion
Type 1 DM
Type 2 DM
Pre-Diabetes
Gestational Diabetes
Caution concentration of insulin
U-100
U-200
U-500
U-300
Which of the following types of Insulin can be administered IV
Regular
Rapid Acting
Mixtures
Long Acting
U-100 3mL pen contains how many units of Insulin
33.3 Units
103 Units
30 Units
300 Units
Insulin’s that end in LIN R class (NovoLIN R, HumuLIN R)
Rapid Acting
Short Acting
Intermediate Acting
Long Acting
Short acting insulin’s should be taken:
Once in the morning
15 mins before meal
30 mins before meal
Once at night
Analog Insulin’s are found in what category
Long acting Insulins
Intermediate acting Insulins
Short acting Insulins
Rapid acting insulins
Glulisine (Apidra) class
Rapid acting insulin
Short acting insulin
Long acting insulin
Ultra long acting insulin
Select the Rapid acting BIOSIMILARS that can be taken with meal or after
Apidra
Insulin Aspart
Insulin Lispro aabc
NovoLOG
Select the inhaled Rapid acting Insulin that shouldn’t be taken with chronic lung disease pts
Apidra (Glulisine)
Afrezza (technosphere)
Aspart (NovoLOG)
Lispro (HumaLog)
How are basal Insulins typically taken
Oral
IV
Subcutaneously
Insulin Glargine (Lantus) Class
Rapid acting
Short acting
Long Acting
Ultra Long acting
Select the U-300 Insulin Glargine Analog
Lantus
Basaglar
Detemir
Toujeo
Which of the following basals is typically given twice a day due to a shorter half-life
Insulin Detemir (Levemir)
Insulin Glargine (Lantus)
NPH
Insulin Degludec (Tresiba)
Insulin Degludec (Tresiba) Class
Rapid Acting
Short Acting
Intermediate acting
Ultra-Long acting
Which of the following shouldn’t be thrown away for cloudy appearance
Tresiba
Lemevir
Glargine
NPH Insulin
NPH insulin class
Rapid Acting
Short Acting
Intermediate acting
Long acting
HumuLIN 70/30
70% Aspart protamine and 30% insulin aspart
70% Lispro protamine and 30% lispro injection
70% Lispro protamine and 30% regular
70% NPH and 30% regular
NovoLog 70/30
NPH and regular
Apart protamine and insulin aspart
Lispro protamine and lispro injection
NPH and Insulin Aspart
Lispro protamine + lispro injection
Nuvolog Mix
HumuLIN Mix
HumaLOG mix
What is true about dosing insulin (Select all)
2 units / kg
Around 50/50 basal/bolus
Around 75/25 basal/bolus
.5 units/ kg
Correction Factor= How much one unit of insulin will drop glucose levels
True
False
DPP-4 helps initiate GIP and GLP-1 effect after eating
True
False
There is increased glucose reabsorption by SGLT transporters in the kidney in patients with T2 diabetes
True
False
Select all of the injectable agents used for type 2 diabetes
GLP-1 Receptor agonists
Thiazolidinediones
Amylin mimetics
Insulins
Insulin has the highest efficacy for A1C
True
False
Drug class that inhibits ATP dependent K+ channels in Beta cells and squeezes insulin out like a sponge
SGLT-2 inhibitors
Sulfonureas
Amylin Mimetics
TZDs
Select the side effects seen in Sulfonylureas
Weight loss
Weight Gain
Hypoglycemia
Hyperglycemia
Select the first gen sulfonylurea
Tolbutamide
Glyburide
Glimepiride
Pramlintide
GLUCOSE DEPENDENT class that inhibit K+ channels in Beta Cells and squeeze insulin release from functional Beta Cells
Meglitinides
TZD
SGLT-2 inhibitors
DPP-4 inhibitor
Repaglinide and Nateglinide Class
TZD
DPP-4 inhibitors
Meglitinides
SGLT-2 inhibitors
Select all true about metformin MOA
Primary effect on Liver, Decreases hepatic glucose production
Secondary effect on peripheral tissue, increase of uptake in fat and muscle
Decrease insulin sensitivity
Increases insulin secretion
Side effects with metformin
Weight loss
ASCVD Benefit
Hypoglycemia
Renal Dosing necessary
Lactic Acidosis
Which eGFR level is contraindicated with Metformin use
>60
45-60
30-45
<30
Drug class with strong Gamma effects, who’s primary’s effect is increase uptake of insulin in peripheral tissue, secondary effect is decrease glucose production in liver
SGLT-2 Inhibitor
DPP-4
Sulfonylureas
TZD inhibitors
Rosglitazone and Pioglitazone Class
SGLT-2 Inhibitor
DPP-4 Inhibitor
Sulfonylureas
TZD inhibitors
Which TZD is linked to Bladder Cancer
Rosiglitazone
Pioglitazone
TZDs have a severe ADR of HF, Macular Edema, Bone fractures
True
False
TZD that increases risk of MI
Rosiglitazone
Pioglitazone
Your patient is at risk for HF, which DPP-4 inhibitor should you avoid prescribing
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Drugs that end in “gliptin” class
DPP-4 Inhibitors
SGLT-2 Inhibitors
TZD inhibitors
Sulfonylureas
Drugs that end in “gliflozin” class
DPP-4 Inhibitors
Sulfonylureas
TZD inhibitors
SGLT-2 Inhibitors
Select the SGLT-2 inhibitor that LACKS any beneficial cardiac effects
Empagliflozin
Canagliflozin
Dapagliflozin
Ertugliflozin
Select the SGLT-2 inhibitor that is beneficial for T2DM, decreases the risk of MACE, AND decreases the risk of End stage Kidney disease
Empagliflozin
Canagliflozin
Dapagliflozin
Ertugliflozin
Select all of the GLP-1 agonists that decrease the risk of MACE, and have renal benefits
Dulaglutide
Exenatide
Liraglutide
Lixisenatide
Semaglutide
When adding Insulin to a patient with Type 2 DM regimen, what should you start with
10 units Bolus
15 units Bolus
10 units Basal
15 units basal
Select the Alpha-glucosidase inhibitors (GI ADRs)
Sitagliptin
Empagliflozin
Acarbose
Miglitol
Pramlintidine class
Sulfonylurea
Amylin Mimetic
DPP-4 Inhibitor
SGLT-2 inhibitor
When to start treating for hypoglycemia -BG level
Less than 100
Less than 50
Less than 70
Greater than 140
Levothyroxine class
Antithyroid agent
Thyroid replacement
Sulfonylurea
DPP-4 inhibitor
Methimazole class
Antithyroid agent
Thyroid replacement
Sulfonylurea
GLP-1 inhibitor
